Scinovex
articleTop 1% cited

18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec®)

European Journal of Cancer · 2003 · Vol. 39(14) · pp. 2012–2020
Sigrid StroobantsJ. GoeminneM. SeegersSaša DimitrijevićPatrick DupontJohan NuytsMarc MartensBen van den BornePascale ColéRaf SciotHerlinde DumezSandra SilbermanLuc MortelmansA. van Oosterom
Sarcoma Diagnosis and TreatmentGastrointestinal Tumor Research and TreatmentVascular Tumors and AngiosarcomasImatinib mesylateMedicinePositron emission tomographySoft tissue sarcomaNuclear medicineMesylateSarcomaSoft tissueRadiologyInternal medicine

MeSH terms

Imatinib MesylateAdultAgedAntineoplastic AgentsBenzamidesFemaleGastrointestinal NeoplasmsHumansMaleMiddle AgedPiperazinesProspective StudiesPyrimidinesSarcomaTomography, Emission-Computed
Citations
526
FWCI
28.28
field-weighted impact
References
30
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.